NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether Ocugen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On April 1, 2024, after the market closed, Ocugen filed a Current Report on Form 8-K with the United States ("U.S.") Securities and Exchange Commission revealing that, in connection with the preparation of the Company's financial statements for the year ended December 31, 2023, Ocugen identified certain accounting errors related to the application of U.S. ...